Quantifying intra-tumoral genetic heterogeneity of glioblastoma toward precision medicine using MRI and a data-inclusive machine learning algorithm
Authors:
Lujia Wang,
Hairong Wang,
Fulvio D'Angelo,
Lee Curtin,
Christopher P. Sereduk,
Gustavo De Leon,
Kyle W. Singleton,
Javier Urcuyo,
Andrea Hawkins-Daarud,
Pamela R. Jackson,
Chandan Krishna,
Richard S. Zimmerman,
Devi P. Patra,
Bernard R. Bendok,
Kris A. Smith,
Peter Nakaji,
Kliment Donev,
Leslie C. Baxter,
Maciej M. Mrugała,
Michele Ceccarelli,
Antonio Iavarone,
Kristin R. Swanson,
Nhan L. Tran,
Leland S. Hu,
Jing Li
Abstract:
Glioblastoma (GBM) is one of the most aggressive and lethal human cancers. Intra-tumoral genetic heterogeneity poses a significant challenge for treatment. Biopsy is invasive, which motivates the development of non-invasive, MRI-based machine learning (ML) models to quantify intra-tumoral genetic heterogeneity for each patient. This capability holds great promise for enabling better therapeutic se…
▽ More
Glioblastoma (GBM) is one of the most aggressive and lethal human cancers. Intra-tumoral genetic heterogeneity poses a significant challenge for treatment. Biopsy is invasive, which motivates the development of non-invasive, MRI-based machine learning (ML) models to quantify intra-tumoral genetic heterogeneity for each patient. This capability holds great promise for enabling better therapeutic selection to improve patient outcomes. We proposed a novel Weakly Supervised Ordinal Support Vector Machine (WSO-SVM) to predict regional genetic alteration status within each GBM tumor using MRI. WSO-SVM was applied to a unique dataset of 318 image-localized biopsies with spatially matched multiparametric MRI from 74 GBM patients. The model was trained to predict the regional genetic alteration of three GBM driver genes (EGFR, PDGFRA, and PTEN) based on features extracted from the corresponding region of five MRI contrast images. For comparison, a variety of existing ML algorithms were also applied. The classification accuracy of each gene was compared between the different algorithms. The SHapley Additive exPlanations (SHAP) method was further applied to compute contribution scores of different contrast images. Finally, the trained WSO-SVM was used to generate prediction maps within the tumoral area of each patient to help visualize the intra-tumoral genetic heterogeneity. This study demonstrated the feasibility of using MRI and WSO-SVM to enable non-invasive prediction of intra-tumoral regional genetic alteration for each GBM patient, which can inform future adaptive therapies for individualized oncology.
△ Less
Submitted 29 December, 2023;
originally announced January 2024.
Deep Learning for Virus-Spreading Forecasting: a Brief Survey
Authors:
Federico Baldo,
Lorenzo Dall'Olio,
Mattia Ceccarelli,
Riccardo Scheda,
Michele Lombardi,
Andrea Borghesi,
Stefano Diciotti,
Michela Milano
Abstract:
The advent of the coronavirus pandemic has sparked the interest in predictive models capable of forecasting virus-spreading, especially for boosting and supporting decision-making processes. In this paper, we will outline the main Deep Learning approaches aimed at predicting the spreading of a disease in space and time. The aim is to show the emerging trends in this area of research and provide a…
▽ More
The advent of the coronavirus pandemic has sparked the interest in predictive models capable of forecasting virus-spreading, especially for boosting and supporting decision-making processes. In this paper, we will outline the main Deep Learning approaches aimed at predicting the spreading of a disease in space and time. The aim is to show the emerging trends in this area of research and provide a general perspective on the possible strategies to approach this problem. In doing so, we will mainly focus on two macro-categories: classical Deep Learning approaches and Hybrid models. Finally, we will discuss the main advantages and disadvantages of different models, and underline the most promising development directions to improve these approaches.
△ Less
Submitted 3 March, 2021;
originally announced March 2021.
